… Systemic therapy is now an integral part of SCCHN treatment. Patients with locally advanced
disease can be offered CRT upfront or as an adjuvant to definitive surgery. Options for …

… We then focused on the integration of systemic therapies with RT, highlighting the latest
published evidence and ongoing trials which investigate different combination strategies in the …

… is the predominant mucosal cancer of the head and neck region. … around the role of systemic
therapies in the management of … cancers compared to the other head and neck cancer …

… treated with either induction or concurrent systemic therapy (as is standard for head and
neck cancer), we excluded patients if systemic therapy was delivered before 100 days before …

… head and neck cancer patients with systemic therapy is … Treatment advice for individual
head and neck cancer patients … of adverse events during systemic therapy is of paramount …

… with squamous cell cancer (SCC), … neck cancers are among the ten most common cancers
globally. In India, they account for one fourth of male cancers and one tenth of female cancers. …

… radiotherapy, to treat advanced head and neck cancers. A series of other novel biologicals
… head and neck cancers. When developing a lasting, individualised systemic tumour therapy, …

… a critical review of evidence of systemic therapy in SCCHN. … the available phase three data
of systemic therapy in various stages of … in head and neck cancer (MACH-NC) and updates …

… and neck cancers … systemic agents available for head and neck squamous cell carcinoma
(HNSCC). However, the last decade has observed increased interest in targeted therapies for …

… of systemic therapy regimens. This review critically evaluates the role of concurrent systemic
therapy with … Of note, we do not discuss the role of induction therapy, which merits its own …